Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of chemical chaperone lumacaftor (VX-809) on gene expression in HEK-293 cells expressing hERG/A561V

ABSTRACT: Effect of chemical chaperone lumacaftor (VX-809) on gene expression in HEK-293 cells expressing hERG/A561V

PROVIDER: PRJNA944609 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23860303_1.fastq.gz	Fastqsanger.gz
	SRR23860303_2.fastq.gz	Fastqsanger.gz
	SRR23860304_1.fastq.gz	Fastqsanger.gz
	SRR23860304_2.fastq.gz	Fastqsanger.gz
	SRR23860305_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Effect of chemical chaperone lumacaftor (VX-809) on gene expression in HEK-293 cells expressing hERG/A561V

Project description:To investigate the molecular effect of lumacaftor in the regulation of mutatant hERG protein expression, we established HEK-293 cell lines expressing hERG/A561V, 15μM lumacaftor treatment as experimental group (HAL) and DMSO treatment (HA) as control group. We then performed gene expression profiling analysis using data obtained from RNA-seq of 2 different groups.

2025-03-12 | GSE227304 | GEO

Distinct proteostasis states drive pharmacologic chaperone susceptibility for Cystic Fibrosis Transmembrane Conductance Regulator misfolding mutants

Project description:Pharmacological chaperones represent a class of therapeutic compounds for treating protein misfolding diseases. One of the most prominent examples is the FDA-approved pharmacological chaperone lumacaftor (VX-809), which has transformed cystic fibrosis (CF) therapy. CF is a fatal disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). VX-809 corrects folding of F508del CFTR, the most common patient mutation, yet F508del exhibits only mild VX-809 response. In contrast, rarer mutations P67L and L206W are hyper-responsive to VX-809, while G85E is non-responsive. Despite the clinical success of VX-809, the mechanistic origin for the distinct susceptibility of mutants remains unclear. Here, we use interactomics to characterize the impact of VX-809 on proteostasis interactions of P67L and L206W and compare these to F508del and G85E. We determine hyper-responsive mutations P67L and L206W exhibit decreased interactions with proteasomal, and autophagy degradation machinery compared to F508del and G85E. We then show inhibiting the proteasome attenuates P67L and L206W VX-809 response. Our data suggests a previously unidentified but required role for protein degradation in VX-809 correction. Furthermore, we present an approach for identifying proteostasis characteristics of mutant-specific therapeutic response to pharmacological chaperones.

2022-05-04 | PXD032836 | Pride

BPA impacts on HEK 293 cells

Project description:BPA impacts on HEK 293 cells

| PRJEB4749 | ENA

Transcriptome analysis of HEK 293 cells after treatment with Quinolinol B23

Project description:This work describes the alteration in the expression of genes in response to quinolinol treatment, we noticed an enrichment in the HEK 293 YAP/TAZ signature

2020-05-08 | GSE130876 | GEO

Homo sapiens strain:HEK 293

Project description:Homo sapiens strain:HEK 293 Raw sequence reads

| PRJNA612416 | ENA

Toxic effects of BDE209 in human embryonic kidney 293 cells (HEK 293)

Project description:PBDEs are widely used in consumer and household products as flame retardants. Many studies have shown that PBDEs could disrupt thyroid hormone homeostasis and adversely affect brain development. Here, we explored the toxical effects of BDE209 on HEK 293 cells and found that BDE209 may have a role in nucleosome remodeling. Many gene sets involved in cancer are enriched at the BDE209-treated sample. This indicates the carcinogenicity of BDE209. Interestingly, the impacts of BDE209 dissoved in DMSO on gene expression are more pronounced than the simple additive effects of BDE209 and DMSO alone. Gene expression profiles of human embryonic kidney 293 cells (HEK 293) cultured in normal medium, and medium containing BDE209 or DMSO were generated by deep sequencing, using Illumina HighSeq2000, respectively..

2014-04-21 | E-GEOD-56361 | biostudies-arrayexpress

Microarray based gene expression profiling of RNA binding protein, RBM10 in HEK 293 cells

Project description:To determine the target genes of RBM10,we have employed microarray based gene expression profiling by knocking down RBM10 in HEK 293 cells. Microarray analysis after RBM10 knockdown on HEK 293 cells showed that over 1000 genes were down regulated while another 800 genes up regulated as a result of the knockdown. Among the down regulated genes, we found the significant presence of cardiovascular disease related genes, especially cardiac hypertrophy and heart failure.

2018-09-13 | GSE114437 | GEO

Homo sapiens strain:hek-293

Project description:Homo sapiens strain:hek-293 Genome sequencing and assembly

| PRJNA1028112 | ENA

HEK-293 cells: Control cells transfected with hRIZ2 and rRIZ1

Project description:In order to evaluate the effects of RIZ2 overexpression on gene expression, a pilot expression study was performed through microarrays analysis. We compared the differential gene expression between HEK-293 cells overexpressing human RIZ2 (pEGFP-hRIZ2) and rat RIZ1 (pEGFP-rRIZ1) versus control cells transfected with the E-GFP empty vector alone (pEGFP).

2020-12-09 | GSE150031 | GEO

Comprehensive mRNA-sequencing-based characterization of three HEK-293 cell lines during an rAAV production process for Gene Therapy Applications

Project description:Human embryonal kidney cells (HEK-293) are the most common host cells used for transient recombinant adeno-associated virus (rAAV) production in pharmaceutical industry. To better cover the expected gene therapy product demands in the future, different traditional strategies such as cell line sub-cloning and/or addition of chemical substances to the fermentation media have been used to maximize titers and improve product quality. A more effective and advanced approach to boost yield can be envisaged by characterizing the transcriptome of different HEK-293 cell line pedigrees with distinct rAAV productivity patterns to subsequently identify potential gene targets for cell engineering. In this work, the mRNA expression profile of three HEK-293 cell lines, resulting in various yields during a fermentation batch process for rAAV production, was investigated to gain basic insight into cell variability and eventually to identify genes that correlate with productivity. Mock runs using only transfection reagents were performed in parallel as a control. We found significant differences in gene regulatory behaviors between the three cell lines at different growth and production stages. The evaluation of these transcriptomics profiles combined with collected in-process control parameters and titers shed some light on potential cell engineering targets to maximize transient production of rAAV in HEK-293 cells Comparison of three HEK-293 suspension cell lines transcriptomics during an AAV production process

2024-05-13 | GSE226054 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data